CSIMarket


Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 
 

BPSR's Capital Expenditures Growth by Quarter and Year

Organicell Regenerative Medicine Inc 's Capital Expenditures results by quarter and year




BPSR Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter October - - - -0.04
III Quarter July 0.18 0.10 0.01 -0.04
II Quarter April - 0.01 0.02 -0.04
I Quarter January 0.05 0.03 - -
FY   0.23 0.14 0.03 -0.12



BPSR Capital Expenditures third quarter 2021 Y/Y Growth Comment
Organicell Regenerative Medicine Inc achieved in the third quarter, above Company average Capital Expenditures rise of 78.55% year on year, to $ 0.18 millions.

Looking into third quarter results within Biotechnology & Pharmaceuticals industry 58 other companies have achieved higher Capital Expenditures growth. While Organicell Regenerative Medicine Inc ' s Capital Expenditures jump of 78.55% ranks overall at the positon no. 885 in the third quarter.




BPSR Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter October - - - -
III Quarter July 78.55 % 900 % - -
II Quarter April - -50 % - -
I Quarter January 66.67 % - - -
FY   - 366.67 % - -

Financial Statements
Organicell Regenerative Medicine Inc 's third quarter 2021 Capital Expenditures $ 0.18 millions BPSR's Income Statement
Organicell Regenerative Medicine Inc 's third quarter 2020 Capital Expenditures $ 0.10 millions Quarterly BPSR's Income Statement
New: More BPSR's historic Capital Expenditures Growth >>


BPSR Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter October - - - -
III Quarter July - 900 % -50 % -
II Quarter April - -66.67 % - -
I Quarter January - - - -
FY (Year on Year)   - 366.67 % - -




Capital Expenditures third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #59
Healthcare Sector #222
Overall #885

Capital Expenditures Y/Y Growth Statistics
High Average Low
839.48 % 69.77 % -100 %
(Jul 31 2020)   (Apr 30 2021)
Capital Expenditures third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #59
Healthcare Sector #222
Overall #885
Capital Expenditures Y/Y Growth Statistics
High Average Low
839.48 % 69.77 % -100 %
(Jul 31 2020)   (Apr 30 2021)

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Organicell Regenerative Medicine Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
1017.12 % 101.09 % -100 %
(Jul 31 2017)  


BPSR's III. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Capital Expenditures Q/Q Growth Statistics
High Average Low
1017.12 % 101.09 % -100 %
(Jul 31 2017)  


BPSR's III. Quarter Q/Q Capital Expenditures Comment


Organicell Regenerative Medicine Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jul 31 2021)
12 Months Ending
(Apr 30 2021)
12 Months Ending
(Jan 31 2021)
12 Months Ending
(Oct 31 2020)
12 Months Ending
(Jul 31 2020)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Jul 31 2021 period, Organicell Regenerative Medicine Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Jul 31 2021 period, Organicell Regenerative Medicine Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Organicell Regenerative Medicine Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Biotechnology & Pharmaceuticals Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BPSR's Capital Expenditures Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BPSR's Competitors
Capital Expenditures Growth for Organicell Regenerative Medicine Inc 's Suppliers
Capital Expenditures Growth for BPSR's Customers

You may also want to know
BPSR's Annual Growth Rates BPSR's Profitability Ratios BPSR's Asset Turnover Ratio BPSR's Dividend Growth
BPSR's Roe BPSR's Valuation Ratios BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio
BPSR's Roa BPSR's Inventory Turnover Ratio BPSR's Growth Rates BPSR's Dividend Comparisons



Companies with similar Capital Expenditures jump for the quarter ending Jul 31 2021 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jul 31 2021
Agilent Technologies inc 120.00%$ 120.000 millions
Organicell Regenerative Medicine Inc 87.03%$ 87.034 millions
Coherent inc 79.88%$ 79.880 millions
Staar Surgical Co74.02%$ 74.025 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SPND's Profile

Stock Price

SPND's Financials

Business Description

Fundamentals

Charts & Quotes

SPND's News

Suppliers

SPND's Competitors

Customers & Markets

Economic Indicators

SPND's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071